Antibiotics: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Overview of Antibiotics

• Common Side Effects of Antibiotics

Classification of Antibiotics

• Cell Wall Inhibitors
• Protein Inhibitors
• DNA Inhibitors
• Other Antibiotic Classes

Overview of Gram-negative and Gram-positive Bacteria
Route of Administration
Trends in the Market for Antibiotics

• Funding for New Antibiotic Development
• Increasing Focus on Antibiotic Drug Development by Smaller Pharmaceutical Firms
• Growing Public-Private Partnerships

Chapter 4 Market Dynamics

Market Drivers

• Growth of the Global Pharmaceutical Market Driven by Antibiotics
• Rise in Geriatric Population and Infection Rate
• Increasing Prevalence of Hospital-acquired Infections
• Improved Awareness about Diseases and their Antibiotics

Market Restraints

• Antibiotic-resistant Infections
• Genericization of Antibiotics and Drugs
• Declining Research and Development (R&D) Investment
• Side Effects of Antibiotics

Market Opportunities

• Market Expansion into Emerging Countries
• Development of Novel Antibacterial Agents

Chapter 5 Market Breakdown by Product

Global Market for Antibiotics by Product

• Cell Wall Inhibitors
• Protein Inhibitors
• DNA Inhibitors
• Other Types of Inhibitors

Chapter 6 Market Breakdown by Route of Administration

Global Market for Antibiotics by Route of Administration

• Oral Antibiotics
• Topical Antibiotics
• Other Routes of Administration

Chapter 7 Market Breakdown by Region

Global Market for Antibiotics by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Chapter 8 Impact of COVID-19 on the Pharmaceutical Industry

Short-term Impact

• Change in Demand
• Shift of Communication and Promotions to Remote Interactions
• Research and Development Changes

Long-term Impact

• Delayed Approvals for Non-COVID-related Pharmaceutical Products
• Self-sufficiency in Pharma Industry
• Pharmaceutical Industry Growth Slow-Down
• Changes in Consumption Trends in Health-related Products

Chapter 9 Clinical Developments and Pipeline Products

Respiratory Tract Infections

Chapter 10 Value Chain Analysis

Introduction
China is a Becoming a Center of Microbial Threats

Chapter 11 Regulatory Scenario

FDA and International Regulation
Recent Regulatory Reforms
Ketek Case Study

Chapter 12 Competitive Landscape

Global Company Market Share Analysis
Mergers, Collaborations, Partnerships and Acquisitions

Chapter 13 Company Profiles

ABBOTT
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MERCK & CO., INC.
MYLAN N.V.
PFIZER INC.
SANOFI
Chapter 14 Appendix: Acronyms

List of Tables

Summary Table A : Global Market for Antibiotics, by Product, Through 2025
Summary Table B : Global Market for Antibiotics, by Route of Administration, Through 2025
Table 1 : Major Differences Between Gram-positive and Gram-negative Organisms
Table 2 : Proportion of Resistant Strains, by WHO Region
Table 3 : Global Market for Antibiotics, by Product, Through 2025
Table 4 : Global Market for Cell Wall Inhibitors, by Region, Through 2025
Table 5 : Global Market for Protein Inhibitors, by Region, Through 2025
Table 6 : Global Market for DNA Inhibitors, by Region, Through 2025
Table 7 : Global Market for Other Types of Inhibitors, by Region, Through 2025
Table 8 : Global Market for Antibiotics, by Route of Administration, Through 2025
Table 9 : Global Market for Oral Antibiotics, by Region, Through 2025
Table 10 : Global Market for Topical Antibiotics, by Region, Through 2025
Table 11 : Global Market for Other Routes of Administration of Antibiotics, by Region, Through 2025
Table 12 : Global Market for Antibiotics, by Region, Through 2025
Table 13 : North American Market for Antibiotics, by Product, Through 2025
Table 14 : North American Market for Antibiotics, by Route of Administration, Through 2025
Table 15 : North American Market for Antibiotics, by Country, Through 2025
Table 16 : European Market for Antibiotics, by Product, Through 2025
Table 17 : European Market for Antibiotics, by Route of Administration, Through 2025
Table 18 : European Market for Antibiotics, by Country, Through 2025
Table 19 : Asia-Pacific Market for Antibiotics, by Product, Through 2025
Table 20 : Asia-Pacific Market for Antibiotics, by Route of Administration, Through 2025
Table 21 : Asia-Pacific Market for Antibiotics, by Country, Through 2025
Table 22 : Latin American Market for Antibiotics, by Product, Through 2025
Table 23 : Latin American Market for Antibiotics, by Route of Administration, Through 2025
Table 24 : Latin American Market for Antibiotics, by Country, Through 2025
Table 25 : Middle Eastern and African Market for Antibiotics, by Product, Through 2025
Table 26 : Middle Eastern and African Market for Antibiotics, by Route of Administration, Through 2025
Table 27 : Middle Eastern and African Market for Antibiotics, by Country, Through 2025
Table 28 : Antibiotics and Combinations in Global Clinical Development and the Pipeline
Table 29 : FDA-Approved Antibacterial Drugs, 2018
Table 30 : FDA-Approved Antibacterial Drugs, 2019
Table 31 : Abbott: Antibiotics Product Portfolio
Table 32 : F. Hoffmann-La Roche AG: Antibiotics Product Portfolio
Table 33 : GlaxoSmithKline Plc: Antibiotics Product Portfolio
Table 34 : Johnson & Johnson: Antibiotics Product Portfolio
Table 35 : Merck & Co., Inc.: Antibiotics Product Portfolio
Table 36 : Merck & Co., Inc.: Antibiotic Drugs Overview
Table 37 : Mylan N.V.: Antibiotics Product Portfolio
Table 38 : Pfizer Inc.: Antibiotics Product Portfolio
Table 39 : Pfizer Inc.: Antibiotic Drugs Overview
Table 40 : Sanofi: Antibiotics Product Portfolio
Table 41 : Sanofi S.A.: Antibiotic Drugs Overview
Table 42 : Acronyms Used in this Report

List of Figures

Summary Figure A : Global Market Shares of Antibiotics, by Product, 2019
Summary Figure B : Global Market Shares of Antibiotics, by Route of Administration, 2019
Figure 1 : Share of API Manufacturing Facilities for All Drugs, by Country/Region, August 2019
Figure 2 : Share of Population Aged 65 Years or Over, by Region, 2019
Figure 3 : Forecasted Share of Population Aged 65 Years or Over, by Region, 2050
Figure 4 : Increase in Aging Population, 2011 and 2050
Figure 5 : Distribution of Population with HAIS in the U.S., 2014
Figure 6 : Major Socioeconomic and Political Factors Contributing to Antibiotic Resistance
Figure 7 : Global Market Shares of Antibiotics, by Product, 2019
Figure 8 : Global Market for Cell Wall Inhibitors, 2018-2025
Figure 9 : Global Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
Figure 10 : Global Market for Cell Wall Inhibitors, by Region, 2018-2025
Figure 11 : Global Market for Protein Inhibitors, 2018-2025
Figure 12 : Global Market Shares of Antibiotics, by Protein Inhibitor, 2019
Figure 13 : Global Market for Protein Inhibitors, by Region, 2018-2025
Figure 14 : Global Market for DNA Inhibitors, 2018-2025
Figure 15 : Global Market Shares of Antibiotics, by DNA Inhibitor, 2019
Figure 16 : Global Market for DNA Inhibitors, by Region, 2018-2025
Figure 17 : Global Market for Other Types of Inhibitors, 2018-2025
Figure 18 : Global Market for Other Types of Inhibitors, by Region, 2018-2025
Figure 19 : Global Market Shares of Antibiotics, by Route of Administration, 2019
Figure 20 : Global Market for Oral Antibiotics, 2018-2025
Figure 21 : Global Market for Oral Antibiotics, by Region, 2018-2025
Figure 22 : Global Market for Topical Antibiotics, 2018-2025
Figure 23 : Global Market for Topical Antibiotics, by Region, 2018-2025
Figure 24 : Global Market for Other Routes of Administration of Antibiotics, 2018-2025
Figure 25 : Global Market for Other Routes of Administration of Antibiotics, by Region, 2018-2025
Figure 26 : Global Market Shares of Antibiotics, by Region, 2019
Figure 27 : North American Market Shares of Antibiotics, by Product, 2019
Figure 28 : North American Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
Figure 29 : North American Market Shares of Antibiotics, by Protein Inhibitor, 2019
Figure 30 : North American Market Shares of Antibiotics, by DNA Inhibitor, 2019
Figure 31 : North American Market Shares of Antibiotics, by Route of Administration, 2019
Figure 32 : North American Market Shares of Antibiotics, by Country, 2019
Figure 33 : U.S. Market for Antibiotics, 2018-2025
Figure 34 : Canadian Market for Antibiotics, 2018-2025
Figure 35 : Mexican Market for Antibiotics, 2018-2025
Figure 36 : European Market Shares of Antibiotics, by Product, 2019
Figure 37 : European Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
Figure 38 : European Market Shares of Antibiotics, by Protein Inhibitor, 2019
Figure 39 : European Market Shares of Antibiotics, by DNA Inhibitor, 2019
Figure 40 : European Market Shares of Antibiotics, by Route of Administration, 2019
Figure 41 : European Market Shares of Antibiotics, by Country, 2019
Figure 42 : German Market for Antibiotics, 2018-2025
Figure 43 : French Market for Antibiotics, 2018-2025
Figure 44 : U.K. Market for Antibiotics, 2018-2025
Figure 45 : Italian Market for Antibiotics, 2018-2025
Figure 46 : Spanish Market for Antibiotics, 2018-2025
Figure 47 : Rest of the European Market for Antibiotics, 2018-2025
Figure 48 : Asia-Pacific Market Shares of Antibiotics, by Product, 2019
Figure 49 : Asia-Pacific Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
Figure 50 : Asia-Pacific Market Shares of Antibiotics, by Protein Inhibitor, 2019
Figure 51 : Asia-Pacific Market Shares of Antibiotics, by DNA Inhibitor, 2019
Figure 52 : Asia-Pacific Market Shares of Antibiotics, by Route of Administration, 2019
Figure 53 : Asia-Pacific Market Shares of Antibiotics, by Country, 2019
Figure 54 : Japanese Market for Antibiotics, 2018-2025
Figure 55 : Chinese Market for Antibiotics, 2018-2025
Figure 56 : Indian Market for Antibiotics, 2018-2025
Figure 57 : Australia and New Zealand Market for Antibiotics, 2018-2025
Figure 58 : Rest of Asia-Pacific Market for Antibiotics, 2018-2025
Figure 59 : Latin American Market Shares of Antibiotics, by Product, 2019
Figure 60 : Latin American Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
Figure 61 : Latin American Market Shares of Antibiotics, by Protein Inhibitor, 2019
Figure 62 : Latin American Market Shares of Antibiotics, by DNA Inhibitor, 2019
Figure 63 : Latin American Market Shares of Antibiotics, by Route of Administration, 2019
Figure 64 : Latin American Market Shares of Antibiotics, by Country, 2019
Figure 65 : Brazilian Market for Antibiotics, 2018-2025
Figure 66 : Argentinian Market for Antibiotics, 2018-2025
Figure 67 : Rest of Latin American Market for Antibiotics, 2018-2025
Figure 68 : Middle Eastern and African Market Shares of Antibiotics, by Product, 2019
Figure 69 : Middle Eastern and African Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
Figure 70 : Middle Eastern and African Market Shares of Antibiotics, by Protein Inhibitor, 2019
Figure 71 : Middle Eastern and African Market Shares of Antibiotics, by DNA Inhibitor, 2019
Figure 72 : Middle Eastern and African Market Shares of Antibiotics, by Route of Administration, 2019
Figure 73 : Middle Eastern and African Market Shares of Antibiotics, by Country, 2019
Figure 74 : Market for Antibiotics in the GCC Countries, 2018-2025
Figure 75 : South African Market for Antibiotics, 2018-2025
Figure 76 : Rest of Middle Eastern and African Market for Antibiotics, 2018-2025
Figure 77 : Impact of COVID-19 on the Pharmaceutical Industry
Figure 78 : Global Market Shares of Antibiotics, by Manufacturer, 2019
Figure 79 : Abbott: Annual Revenue, 2016-2019
Figure 80 : Abbott: Revenue Shares, by Country/Region, 2019
Figure 81 : Abbott: Revenue Shares, by Business Unit, 2019
Figure 82 : F. Hoffmann-La Roche AG: Annual Revenue, 2016-2019
Figure 83 : F. Hoffmann-La Roche AG: Revenue Shares in Pharmaceutical Segment, by Country/Region, 2019
Figure 84 : F. Hoffmann-La Roche AG: Revenue Shares, by Business Segment, 2019
Figure 85 : GlaxoSmithKline Plc: Annual Revenue, 2016-2019
Figure 86 : GlaxoSmithKline Plc: Revenue Shares, by Pharmaceuticals, 2019
Figure 87 : Johnson & Johnson: Annual Revenue, 2016-2019
Figure 88 : Johnson & Johnson: Revenue Shares, by Region, 2019
Figure 89 : Johnson & Johnson: Revenue Shares, by Business Unit, 2019
Figure 90 : 90Merck & Co., Inc.: Annual Revenue, 2016-2019
Figure 91 : Merck & Co., Inc.: Revenue Shares, by Region, 2019
Figure 92 : Merck & Co., Inc.: Revenue Shares, by Business Unit, 2019
Figure 93 : Mylan N.V.: Annual Revenue, 2016-2019
Figure 94 : Mylan N.V.: Revenue Shares, by Region, 2019
Figure 95 : Mylan N.V.: Revenue Shares, by Business Unit, 2019
Figure 96 : Pfizer Inc.: Annual Revenue, 2016-2019
Figure 97 : Pfizer Inc.: Revenue Shares, by Country/Region, 2019
Figure 98 : Pfizer Inc.: Revenue Shares, by Business Segment, 2019
Figure 99 : Sanofi: Annual Revenue, 2016-2019
Figure 100 : Sanofi: Revenue Shares, by Region/Country, 2019
Figure 101 : Sanofi: Revenue Shares, by Business Segment, 2019

当レポートのプレスリリースは発行されておりません。